The Ultimate Litmus Test: Nunes vs. Harrison
AI-generated image · Bay Street Wire
As two legends clash at UFC 334, the bout serves as a critical measure of whether women's MMA can recapture its commercial peak.
The upcoming UFC 334 main event in New York is more than a title fight; it is a test of the commercial viability of women's MMA. As Sportsnet first reported, the bout between Amanda Nunes and Kayla Harrison is arguably the biggest women's fight the UFC has ever staged, arriving after a lull where the current generation struggled to match the pace of pioneers like Ronda Rousey, Cris Cyborg, and Holly Holm.
Nunes, a 38-year-old returning from a three-year retirement, once headlined events that exceeded one million pay-per-view buys and earned reported payouts of $500,000. Sportsnet notes that it is difficult to imagine any current fighter reaching those numbers, with the exception of Nunes and Harrison. This makes the bout a definitive moment for the sport's marketability.
However, the fight arrives with significant physical questions. Harrison, 36, is returning from a two-level spinal fusion to stabilize vertebrae and relieve nerve pain and arm weakness. Nunes is returning from an extended layoff. Sportsnet reports that while Nunes possesses game-changing power, Harrison is a two-time Olympic judo champion. The fight is framed as a classic striking versus grappling matchup, though both were former teammates at American Top Team.
Beyond the technical battle, the commercial stakes are high. Because no other fighters in the 135-pound division approach the profile of these two women, the UFC put the fight on ice for 10 months rather than crowning an interim champion. As Sportsnet observes, the result will not only determine who holds the bantamweight title following Harrison's first defense but will signal if the UFC can sustain a women's main event as a legitimate blockbuster powerhouse.